A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF RO7247669 COMBINED WITH NAB-PACLITAXEL COMPARED WITH PEMBROLIZUMAB COMBINED WITH NAB-PACLITAXEL IN PARTICIPANTS WITH PREVIOUSLY UNTREATED, PD-POSITIVE, LOCALLY-ADVANCED UNRESECTABLE OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Details
Age
Adult
Locations
CTRC Inpatient
Lone Tree Medical Center
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Jennifer Diamond
Study ID
Protocol Number: 23-1623
More information available at ClinicalTrials.gov: NCT05852691
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers